Pointe Bio is a research and development manufacturer of in vitro diagnostic reagents, dedicated to providing customers with high-quality in vitro diagnostic products and services, and becoming a trusted IVD product supplier for customers. Recently, Yahuilong will hold a 52.64% stake in Pointe by acquiring part of the equity of Pointe and increasing its capital, and Pointe will also become a holding subsidiary of Yahuilong.
This article is reprinted from: https://www.itjuzi.com/merger/9378
This site is for inclusion only, and the copyright belongs to the original author.